Market Challenges And Opportunities

Global Diabetic Foot Ulcers Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of things from one place to another.
However, the COVID-19 pandemic had a negative impact on the global diabetic foot ulcers treatment market, owing to a reduction in bed and operating room capacity, which further led to considerable delays in urgent and semi-elective surgical interventions. According to an American College of Surgeons (ACS) 2021 report, the nature of surgery and anesthesia practices changed during the COVID-19 pandemic as the most elective and non-urgent cases were postponed.

Global Diabetic Foot Ulcers Treatment Market: Restraint

The Lack of self-awareness towards the disease management

The lack of self-care management, insufficient support, treatment-oriented approaches, and all clients’ insufficient access to these services are some of the problems that still exist in the care and management of diabetic foot ulcers. These challenges contribute to the high rates of complications and amputations associated with diabetic foot ulcers. Additionally, the limited education and awareness about preventive measures further exacerbate the problem, emphasizing the need for comprehensive and accessible healthcare services for individuals with diabetic foot ulcers.

Global Diabetic Foot Ulcers Treatment Market– Drivers

Increasing incidence of diabetic foot ulcers: The incidence of diabetic foot ulcers is approximately 1500 per 100,000 diabetic individuals worldwide. Among U.S. veterans, the incidence of active diabetic foot ulcers is approximately 500 per 100,000 individuals. On the other hand, the incidence of active diabetic foot ulcers in the U.K. has been estimated at 220 per 100,000 individuals. Furthermore, its prevalence has been reported at 170 per 100,000 individuals among the United Kingdom population. The 5-year risk of mortality in diabetic patients with a foot ulcer is 2.5 times higher than in diabetic individuals without a foot ulcer.

Restraints & Challenges: